UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTL
1351
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $3.84M | ﹤0.01% |
517,388
+44,427
| +9% | +$313K |
|
1352
Home BancShares
HOMB
$6.17B
| $3.84M | ﹤0.01% |
197,118
-7,101
| -3% | -$129K |
|
|
TWOU
1353
DELISTED
2U Inc
TWOU
| $3.84M | ﹤0.01% |
3,199
+1,101
| +52% | +$1.18M |
|
1354
AMN Healthcare
AMN
$1.42B
| $3.83M | ﹤0.01% |
56,074
+3,133
| +6% | +$204K |
|
1355
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$20B
| $3.81M | ﹤0.01% |
810,983
+144,913
| +22% | +$640K |
|
1356
Insmed
INSM
$29.4B
| $3.79M | ﹤0.01% |
113,903
+10,267
| +10% | +$375K |
|
|
TECX
1357
Tectonic Therapeutic
TECX
$639M
| $3.79M | ﹤0.01% |
22,651
-2,074
| -8% | -$369K |
|
1358
John Wiley & Sons Class A
WLY
$2.62B
| $3.76M | ﹤0.01% |
82,352
+2,277
| +3% | +$82.5K |
|
1359
Navient
NAVI
$796M
| $3.76M | ﹤0.01% |
382,482
-51,081
| -12% | -$485K |
|
|
TGNA
1360
DELISTED
TEGNA Inc
TGNA
| $3.75M | ﹤0.01% |
268,776
-8,331
| -3% | -$111K |
|
|
SEM
1361
DELISTED
Select Medical
SEM
| $3.74M | ﹤0.01% |
251,085
-5,754
| -2% | -$75.1K |
|
1362
Houlihan Lokey
HLI
$8.62B
| $3.73M | ﹤0.01% |
55,468
+1,908
| +4% | +$124K |
|
1363
Unifirst Corp
UNF
$5.24B
| $3.72M | ﹤0.01% |
17,590
| – | – |
|
1364
Corcept Therapeutics
CORT
$12.3B
| $3.72M | ﹤0.01% |
142,285
+33,064
| +30% | +$697K |
|
|
APLS
1365
DELISTED
Apellis Pharmaceuticals
APLS
| $3.71M | ﹤0.01% |
64,947
-1,908
| -3% | -$80.7K |
|
1366
Sensient Technologies
SXT
$5.51B
| $3.71M | ﹤0.01% |
50,341
-1,141
| -2% | -$79.6K |
|
|
MAXR
1367
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.7M | ﹤0.01% |
95,847
+42,300
| +79% | +$1.24M |
|
|
AHRT
1368
AH Realty Trust
AHRT
$503M
| $3.7M | ﹤0.01% |
329,561
+31,999
| +11% | +$324K |
|
1369
LCI Industries
LCII
$2.55B
| $3.69M | ﹤0.01% |
28,463
+96
| +0.3% | +$11.8K |
|
1370
Community Bank
CBU
$3.37B
| $3.69M | ﹤0.01% |
59,211
-537
| -0.9% | -$32.9K |
|
1371
Blackbaud
BLKB
$2.09B
| $3.69M | ﹤0.01% |
64,059
+3,786
| +6% | +$211K |
|
|
NGHC
1372
DELISTED
National General Holdings Corp
NGHC
| $3.68M | ﹤0.01% |
107,719
+13,615
| +14% | +$464K |
|
1373
PROG Holdings
PRG
$1.68B
| $3.68M | ﹤0.01% |
+68,255
| New | +$3.52M |
|
1374
Kennametal
KMT
$2.41B
| $3.67M | ﹤0.01% |
101,323
-9,305
| -8% | -$320K |
|
1375
Upwork
UPWK
$1.21B
| $3.67M | ﹤0.01% |
106,226
+29,567
| +39% | +$845K |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.